EP2983638A1 - Cosmetic formulation containing copolymer and sulfosuccinate and/or biosurfactant - Google Patents

Cosmetic formulation containing copolymer and sulfosuccinate and/or biosurfactant

Info

Publication number
EP2983638A1
EP2983638A1 EP14715574.1A EP14715574A EP2983638A1 EP 2983638 A1 EP2983638 A1 EP 2983638A1 EP 14715574 A EP14715574 A EP 14715574A EP 2983638 A1 EP2983638 A1 EP 2983638A1
Authority
EP
European Patent Office
Prior art keywords
weight
parts
alkyl
solution
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP14715574.1A
Other languages
German (de)
French (fr)
Inventor
Peter Schwab
Uta Kortemeier
Christian Hartung
Ursula Westerholt
Silke LANGER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Operations GmbH
Original Assignee
Evonik Degussa GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Degussa GmbH filed Critical Evonik Degussa GmbH
Publication of EP2983638A1 publication Critical patent/EP2983638A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/12Preparations containing hair conditioners
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30Characterized by the absence of a particular group of ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/48Thickener, Thickening system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/596Mixtures of surface active compounds

Definitions

  • Cosmetic formulation containing copolymer as well as sulfosuccinate and / or biosurfactant
  • the present invention relates to formulations comprising certain copolymers and at least one surfactant selected from the group consisting of sulfosuccinates and biosurfactants.
  • compositions to achieve sufficiently high viscosities for formulations containing sulfosuccinates or biosurfactants.
  • Carbomeric thickeners for use in cosmetics are known; such carbomers are generally copolymers of (meth) acrylic acid and alkyl (meth) acrylates which, when neutralized with, for example, alkali in aqueous solution, have thickening properties.
  • EP1953176 and EP 1950231 describe carbomers which, in contrast to conventional carbomers, have the property of providing, in the presence of salt, neutralized solutions which do not decrease in viscosity or transmission.
  • the object of the invention was to thicken cosmetic formulations containing sulfosuccinates or biosurfactants.
  • the present invention therefore relates to formulations comprising certain copolymers and at least one surfactant selected from the group consisting of sulfosuccinates and biosurfactants.
  • Another object of the invention is the use of certain copolymers for thickening cosmetic formulations containing sulfosuccinates or
  • Advantage of the present invention is that particularly mild, surfactant
  • Another advantage of the present invention is that the formulations leave no sticky skin feel.
  • Another advantage of the present invention is that the formulations have good temperature stability, both warm and cold.
  • Another advantage of the present invention is that the formulations have good foam quality.
  • Another advantage of the present invention is that the formulations have good foam stability.
  • Another advantage of the present invention is that the formulations foam quickly.
  • Another advantage of the present invention is that the formulations have a low content of WAS and are therefore economically favorable.
  • Another advantage of the present invention is that the formulations moisturize the skin well. Present.
  • Another advantage of the present invention is that the formulations are readily washable.
  • Heating can be produced.
  • Another advantage of the present invention is that the formulations are very well reproducible, in particular with regard to the viscosity.
  • formulations contain insoluble additives, e.g. Oil phases, stabilize or solubilize.
  • the present invention therefore relates to cosmetic formulations containing
  • alkyl acrylate or alkyl methacylate wherein the alkyl group is selected from alkyl groups having 12 to 24 carbon atoms and
  • a neutralized, 1 wt .-% solution of the polymer in water has a viscosity of 1500 mPa s or lower and a transmission of 90% or higher
  • this solution with an addition of 0.25 to 7 parts by weight NaCl to 100 parts by weight of this Solution has a highest viscosity of 10,000 to 40,000 mPa s and a transmission of 90% or higher
  • neutralized solution in connection with the present invention means a solution of the polymer which has been adjusted to a pH of 7.0, measured at 25 ° C.
  • the viscosity reported in connection with the present invention is measured at 25 ° after one minute rotation at a rotational speed of 20 rpm using a BH type rotary viscometer and a spindle # 6.
  • the transmission reported in the context of the present invention is measured at a wavelength of 425 nm in a cuvette with a light path of 1 cm after degassing the sample by centrifugation.
  • biosurfactant is understood to mean any glycolipid produced by fermentation.
  • the formulation according to the invention contains a component A) which contains at least one alkyl-modified carboxyl group
  • alkyl group is selected from alkyl groups having 18 to 24 carbon atoms and
  • 0 to 0.1 preferably 0.001 to 0.1, particularly preferably 0.001 to 0.044,
  • a neutralized, 1 wt .-% solution of the polymer in water has a viscosity of 1500 mPa s or lower and a transmission of 90% or higher
  • this solution with an addition of 0.25 to 5 parts by weight NaCl to 100 parts by weight of this Solution has a highest viscosity of 15,000 to 40,000 mPa s and a transmission of 90% or higher
  • the formulation of the invention contains a component A) containing at least one alkyl-modified
  • Carboxyl-containing, water-soluble copolymer which is obtainable by polymerization of
  • 0 to 0.1 preferably 0.001 to 0.1, particularly preferably 0.001 to 0.044,
  • a neutralized, 1 wt .-% solution of the polymer in water has a viscosity of 1000 mPa s or lower and a transmission of 95% or higher, and this solution with an addition of 1 to 7 parts by weight NaCl to 100
  • Parts by weight of this solution has a highest viscosity of 10,000 to 30,000 mPa s and a transmission of 95% or higher,
  • copolymers according to the invention contained in the formulations can be prepared by processes known per se, a detailed process description for the preparation of the copolymers according to the invention is described in EP1953176 and EP 1950231.
  • Preferred formulations according to the invention are characterized in that the substance containing two or more ethylenically unsaturated radicals is selected from the group consisting of pentaerythritol allyl ether, diethylene glycol diallyl ether, polyethylene glycol diallyl ether and polyallyl sucrose.
  • the proportion of component A) in the formulation according to the invention is preferably from 0.01 to 10 wt .-%, preferably from 0.1 to 5 wt .-% and particularly preferably from 0.5 to 3 wt .-% based on the total formulation.
  • the proportion of component B) in the formulation according to the invention is preferably from 0.1 to 30 wt .-%, preferably from 1 to 20 wt .-% and particularly preferably from 2 to 10 wt .-% based on the total formulation.
  • the formulations according to the invention may contain sulfosuccinates as component B).
  • sulfosuccinates include the salts of alkylsulfosuccinic acid, also referred to as sulfosuccinic acid esters, which include monoesters and / or diesters of sulfosuccinic acid with alcohols, preferably fatty alcohols and in particular ethoxylated fatty alcohols.
  • Preferred sulfosuccinates contain C8-C18 fatty alcohol residues or mixtures of these. Especially preferred
  • Sulfosuccinates contain a fatty alcohol residue derived from ethoxylated fatty alcohols. Sulfosuccinates, whose fatty alcohol residues are derived from ethoxylated fatty alcohols with a narrow homolog distribution, are again particularly preferred. Likewise, it is also possible to use alk (en) ylsuccinic acid having preferably 8 to 18 carbon atoms in the Al k (en) yl chain or salts thereof. Particularly preferred sulfosuccinates are PEG and sulfate free.
  • PEG and sulfate-free sulfosuccinates are the monosulfosuccinates of polyglyceryl-6-cocoate, polyglyceryl-4-caprate, polyglyceryl-4-caprylate, polyglyceryl-3-caprate or polyglyceryl-3-caprylate and mixtures thereof.
  • Particularly preferred PEG and sulfate-free sulfosuccinates and their preparation are described in PCT / EP2013 / 050367.
  • the formulation according to the invention preferably comprises as component B) "biosurfactant" rhamnolipids, sophorolipids, glucoselipids, celluloselipids and / or trehaloselipids, preferably rhamnolipids and / or sophorolipids
  • biosurfactants in particular glycolipid surfactants, can be obtained, for example, as described in EP 0 499 434, US Pat 7,985,722, WO 03/006146, JP 60-183032, DE 19648439, DE 19600743, JP 01-304034, CN 1337439, JP 2006- 274233, KR 2004033376, JP 2006-083238, JP 2006-070231, WO 03/002700, FR 2740779, DE 2939519, US 7,556,654, FR 2855752, EP 1445302, JP 2008-062179 and JP 2007-181789 or the publications cited therein become.
  • Suitable biosurfactants may, for. B. from
  • the formulation according to the invention preferably has rhamnolipids as biosurfactants, in particular mono-, di- or poly-pyrnolipids and / or sophorolipids.
  • the formulation according to the invention particularly preferably has one or more of the rhamnolipids or sophorolipids described in EP 1 445 302 A with the formulas (I), (II) or (III).
  • a preferred formulation according to the invention is characterized in that it contains an additional component C), which is selected from the group of ammonium, phosphonium, imidazolinium or imidazolium interpretation ambiencen
  • Compounds preferably quaternized ammonium group-containing compounds, particularly preferably alkyl quats, such as Cetrimonium Chloride (VARISOFT ® 300), dialkyl quats or esterquats, or from the group of cationic polymers, preferably cationic guar, cationic siloxanes, and Polyquaternium compounds, in particular Polyquaternium 1 to Polyquaternium 94th , especially preferred
  • Polyquaternium 10 and Polyquaternium 1 1, and Silicone Quaternium-22 (ABIL Quat ® T 60 and ABIL ME 45).
  • imidazolium group-containing compound in the context of the present invention includes compounds which, under the conditions of the given formulation, for example due to the pH, predominantly on the
  • Such substances are preferably selected from the group of aminosiloxanes, particularly preferably aminopropyl dimethicones (ABIL Soft AF 200) or amodimethicones.
  • the proportion of component C) in the formulation according to the invention is preferably from 0.05 to 30 wt .-%, preferably from 0.2 to 20 wt .-% and particularly preferably from 0.5 to 10 wt .-% based on the total formulation.
  • formulations according to the invention are preferred which are substantially free of alkoxylated compounds.
  • the formulations do not contain appreciable amounts of alkoxylated compounds which exert a surface-active action, in particular by the fact that these compounds are present in amounts of less than 1% by weight of less than 0.1% by weight, more preferably less than 0.01% by weight, based on the total formulation, in particular no detectable amounts.
  • formulations according to the invention are preferred which are substantially free of sulphates.
  • substantially sulphate-free in the
  • sulfated organic compounds in amounts of less than 1 wt .-%, preferably less than 0.1 wt .-%, particularly preferably less than 0.01 wt .-% based on the total formulation, in particular no
  • sulphate-containing surfactants are sodium laureth sulphates, sodium lauryl sulphates, ammonium laureth sulphates,
  • Very particularly preferred formulations according to the invention are essentially sulfate-free and substantially free of alkoxylated compounds.
  • Another object of the present invention is the use of the copolymers defined above as component A) for the thickening of cosmetic
  • Formulations containing at least one surfactant selected from the group consisting of sulfosuccinates and biosurfactants are included in Formulations containing at least one surfactant selected from the group consisting of sulfosuccinates and biosurfactants.
  • Preferred use according to the invention uses the components A) mentioned above as preferred.
  • Novethix ® L-10 (INCI: Acrylates Beheneth-25 Methacrylate Copolymer [Novethix TM L-10 polymer] manufactured by Lubrizol Advanced Materials, Inc. /) requires either a lot of additional salt, or no thickening effect shows ,
  • guar-quat and polyquaternium 10 additionally enhance the thickening of a sulfosuccinate and biosurfactant formulation by the carbomer.
  • Coco Glucoside 50% 2.30 2.30 2.30 2.30 2.30 2.30
  • ANTIL ® SPA 80 (Isostearamide MI PA;
  • Citric Acid 2.00% Mild Hair & Body Shampoo; PEG and sulfate free
  • ANTIL ® SPA 80 (Isostearamide MI PA;
  • Citric Acid (3.00%
  • LACTIL ® Sodium Lactate, Sodium PCA
  • LACTIL ® Sodium Lactate, Sodium PCA

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

The present invention relates to formulations containing particular copolymers and at least one surfactant selected from the group consisting of sulfosuccinates and biosurfactants.

Description

E V O N I K I n d u s t r i e s AG  E V O N I K i n d u s t r i e s AG
Kosmetische Formulierung enthaltend Copolymer sowie Sulfosuccinat und/oder Biotensid Cosmetic formulation containing copolymer as well as sulfosuccinate and / or biosurfactant
Gebiet der Erfindung Field of the invention
Gegenstand der vorliegenden Erfindung sind Formulierungen enthaltend bestimmte Copolymere und mindestens ein Tensid ausgewählt aus der Gruppe bestehend aus Sulfosuccinate und Biotenside. The present invention relates to formulations comprising certain copolymers and at least one surfactant selected from the group consisting of sulfosuccinates and biosurfactants.
Stand der Technik Es ist ein lang bekanntes Problem in der Formulierungslehre kosmetischer Background Art It is a long-known problem in the formulation science of cosmetic
Zusammensetzungen, ausreichend hohe Viskositäten für Formulierungen enthaltend Sulfosuccinate oder Biotenside zu erzielen.  Compositions to achieve sufficiently high viscosities for formulations containing sulfosuccinates or biosurfactants.
Carbomere Verdicker zur Verwendung in Kosmetik sind bekannt; solche Carbomere sind in der Regel Copolymere aus (Meth)Acrylsäure und Alkyl-(Meth-)Acrylaten, welche, wenn mit beispielsweise Alkali in wässriger Lösung neutralisiert, verdickende Eigenschaften aufweisen. Carbomeric thickeners for use in cosmetics are known; such carbomers are generally copolymers of (meth) acrylic acid and alkyl (meth) acrylates which, when neutralized with, for example, alkali in aqueous solution, have thickening properties.
Die EP1953176 und EP 1950231 beschreiben Carbomere, welche im Gegensatz zu herkömmlichen Carbomeren die Eigenschaft aufweisen, in Gegenwart von Salz neutralisierte Lösungen bereitzustellen, welche nicht an Viskosität oder Transmission abnehmen.  EP1953176 and EP 1950231 describe carbomers which, in contrast to conventional carbomers, have the property of providing, in the presence of salt, neutralized solutions which do not decrease in viscosity or transmission.
Aufgabe der Erfindung war es, kosmetische Formulierungen enthaltend Sulfosuccinate oder Biotenside zu verdicken. The object of the invention was to thicken cosmetic formulations containing sulfosuccinates or biosurfactants.
Beschreibung der Erfindung Description of the invention
Überraschenderweise wurde gefunden, dass die im Folgenden beschriebenen kosmetischen Formulierungen und die Verwendung der beschriebenen Carbomere die der Erfindung gestellte Aufgabe zu lösen vermögen. Gegenstand der vorliegenden Erfindung sind daher Formulierungen enthaltend bestimmte Copolymere und mindestens ein Tensid ausgewählt aus der Gruppe bestehend aus Sulfosuccinate und Biotenside. Surprisingly, it has been found that the cosmetic formulations described below and the use of the carbomers described are capable of solving the problem addressed by the invention. The present invention therefore relates to formulations comprising certain copolymers and at least one surfactant selected from the group consisting of sulfosuccinates and biosurfactants.
Ein weiterer Gegenstand der Erfindung ist Verwendung der bestimmten Copolymere zur Verdickung kosmetischer Formulierungen enthaltend Sulfosuccinate oder  Another object of the invention is the use of certain copolymers for thickening cosmetic formulations containing sulfosuccinates or
Biotenside. Biosurfactants.
Vorteil der vorliegenden Erfindung ist es, dass besonders milde, tensidische Advantage of the present invention is that particularly mild, surfactant
Formulierungen erhalten werden. Formulations are obtained.
Ein weiterer Vorteil der vorliegenden Erfindung ist es, dass die Formulierungen kein klebriges Hautgefühl hinterlassen. Another advantage of the present invention is that the formulations leave no sticky skin feel.
Ein weiterer Vorteil der vorliegenden Erfindung ist es, dass die Formulierungen eine gute Temperaturstabilität, sowohl im Warmen wie auch im Kalten, aufweisen.  Another advantage of the present invention is that the formulations have good temperature stability, both warm and cold.
Ein weiterer Vorteil der Erfindung ist es, dass die Formulierungen gute Another advantage of the invention is that the formulations are good
Fließeigenschaften aufweisen. Have flow properties.
Ein weiterer Vorteil der vorliegenden Erfindung ist es, dass die Formulierungen eine gute Schaumqualität aufweisen.  Another advantage of the present invention is that the formulations have good foam quality.
Ein weiterer Vorteil der vorliegenden Erfindung ist es, dass die Formulierungen eine gute Schaumstabilität aufweisen.  Another advantage of the present invention is that the formulations have good foam stability.
Ein weiterer Vorteil der vorliegenden Erfindung ist es, dass die Formulierungen schnell anschäumen. Another advantage of the present invention is that the formulations foam quickly.
Ein weiterer Vorteil der vorliegenden Erfindung ist es, das die Formulierungen mit niedriegem Gehalt an WAS auskommen und deshalb ökonomisch günstig sind.  Another advantage of the present invention is that the formulations have a low content of WAS and are therefore economically favorable.
Ein weiterer Vorteil der vorliegenden Erfindung ist es, dass die Formulierungen die Haut gut benetzen. Vorliegenden. Another advantage of the present invention is that the formulations moisturize the skin well. Present.
Ein weiterer Vorteil der vorliegenden Erfindung ist es, dass die Formulierungen gut abwaschbar sind.  Another advantage of the present invention is that the formulations are readily washable.
Ein weiterer Vorteil der vorliegenden Erfindung ist es, dass die Formulierungen ohne Another advantage of the present invention is that the formulations without
Aufheizen herstellbar sind. Heating can be produced.
Ein weiterer Vorteil der vorliegenden Erfindung ist es, dass die Formulierungen insbesondere in Bezug auf die Viskosität sehr gut reproduzierbar sind. Another advantage of the present invention is that the formulations are very well reproducible, in particular with regard to the viscosity.
Ein weiterer Vorteil der vorliegenden Erfindung ist es, dass die Formulierungen unlösliche Zusätze, z.B. Ölphasen, stabilisieren bzw. solubilisieren.  Another advantage of the present invention is that the formulations contain insoluble additives, e.g. Oil phases, stabilize or solubilize.
Ein weiterer Vorteil der vorliegenden Erfindung ist es, dass die Formulierungen sehr hohe Transparenz aufweisen. Gegenstand der vorliegenden Erfindung sind daher kosmetische Formulierungen enthaltend Another advantage of the present invention is that the formulations have very high transparency. The present invention therefore relates to cosmetic formulations containing
A) mindestens ein alkylmodifizierte Carboxylgruppen aufweisendes,  A) at least one alkyl-modified carboxyl group-containing,
wasserlösliches Copolymer, welches erhältlich ist durch Polymerisation von water-soluble copolymer obtainable by polymerization of
100 Gewichtsteilen Acryl- oder Methacylsäure, 100 parts by weight of acrylic or methacrylic acid,
0,5 bis 10 Gewichtsteilen Alkyl-Acrylat oder Alkyl-Methacylat wobei die Alkylgruppe ausgewählt ist aus Alkylgruppen mit 12 bis 24 Kohlenstoffatomen und  From 0.5 to 10 parts by weight of alkyl acrylate or alkyl methacylate wherein the alkyl group is selected from alkyl groups having 12 to 24 carbon atoms and
0 bis 0,1 , bevorzugt 0,001 bis 0,1 , besonders bevorzugt 0,001 bis 0044, Gewichtsteilen einer Substanz enthaltend zwei oder mehr ethylenisch ungesättigte Reste,  0 to 0.1, preferably 0.001 to 0.1, particularly preferably 0.001 to 0044, parts by weight of a substance containing two or more ethylenically unsaturated radicals,
wobei eine neutralisierte, 1 gew.-%ige Lösung des Polymers in Wasser eine Viskosität von 1500 mPa s oder niedriger und eine Transmission von 90 % oder höher aufweist und diese Lösung bei einer Zugabe von 0,25 bis 7 Gewichtsteilen NaCI auf 100 Gewichtsteile dieser Lösung eine höchste Viskosität von 10000 bis 40000 mPa s und eine Transmission von 90 % oder höher aufweist und wherein a neutralized, 1 wt .-% solution of the polymer in water has a viscosity of 1500 mPa s or lower and a transmission of 90% or higher, and this solution with an addition of 0.25 to 7 parts by weight NaCl to 100 parts by weight of this Solution has a highest viscosity of 10,000 to 40,000 mPa s and a transmission of 90% or higher, and
B) mindestens ein Tensid ausgewählt aus der Gruppe bestehend aus  B) at least one surfactant selected from the group consisting of
Sulfosuccinate und Biotenside. Sulfosuccinates and biosurfactants.
Unter dem Begriff„neutralisierte" Lösung ist im Zusammenhang mit der vorliegenden Erfindung eine Lösung des Polymers zu verstehen, die auf einen pH-Wert von 7,0, gemessen bei 25 °C eingestellt wurde. The term "neutralized" solution in connection with the present invention means a solution of the polymer which has been adjusted to a pH of 7.0, measured at 25 ° C.
Die im Zusammenhang mit der vorliegenden Erfindung angegebene Viskosität wird bei 25 ° nach einer Minute Drehen mit einer Rotationsgeschwindigkeit von 20 rpm unter Verwendung eines BH-Typ Rotationsviskosimeters und einer Spindel Nr. 6 gemessen. Die im Zusammenhang mit der vorliegenden Erfindung angegebene Transmission wird bei einer Wellenlänge von 425 nm in einer Küvette mit einem Lichtweg von 1 cm nach Entgasen der Probe durch Zentrifugation gemessen.  The viscosity reported in connection with the present invention is measured at 25 ° after one minute rotation at a rotational speed of 20 rpm using a BH type rotary viscometer and a spindle # 6. The transmission reported in the context of the present invention is measured at a wavelength of 425 nm in a cuvette with a light path of 1 cm after degassing the sample by centrifugation.
Im Rahmen der vorliegenden Erfindung wird unter dem Begriff„Biotensid" jedes durch Fermentation hergestelltes Glycolipid verstanden.  In the context of the present invention, the term "biosurfactant" is understood to mean any glycolipid produced by fermentation.
Alle angegebenen Prozent (%) sind, wenn nicht anders angegeben, Massenprozent. All percentages (%) are by mass unless otherwise specified.
In einer bevorzugten Ausführungsform enthält die erfindungsgemäße Formulierung eine Komponente A), die mindestens ein alkylmodifizierte Carboxylgruppen In a preferred embodiment, the formulation according to the invention contains a component A) which contains at least one alkyl-modified carboxyl group
aufweisendes, wasserlösliches Copolymer, welches erhältlich ist durch Polymerisation von having, water-soluble copolymer which is obtainable by polymerization of
100 Gewichtsteilen Acryl- oder Methacrylsäure, 0,5 bis 5 Gewichtsteilen Alkyl-Acrylat oder Alkyl-Methacrylat wobei die Alkylgruppe ausgewählt ist aus Alkylgruppen mit 18 bis 24 Kohlenstoffatomen und 100 parts by weight of acrylic or methacrylic acid, 0.5 to 5 parts by weight of alkyl acrylate or alkyl methacrylate wherein the alkyl group is selected from alkyl groups having 18 to 24 carbon atoms and
0 bis 0,1 , bevorzugt 0,001 bis 0,1 , besonders bevorzugt 0,001 bis 0,044, 0 to 0.1, preferably 0.001 to 0.1, particularly preferably 0.001 to 0.044,
Gewichtsteilen einer Substanz enthaltend zwei oder mehr ethylenisch ungesättigte Reste, Parts by weight of a substance containing two or more ethylenically unsaturated radicals,
wobei eine neutralisierte, 1 gew.-%ige Lösung des Polymers in Wasser eine Viskosität von 1500 mPa s oder niedriger und eine Transmission von 90 % oder höher aufweist und diese Lösung bei einer Zugabe von 0,25 bis 5 Gewichtsteilen NaCI auf 100 Gewichtsteile dieser Lösung eine höchste Viskosität von 15000 bis 40000 mPa s und eine Transmission von 90 % oder höher aufweist, wherein a neutralized, 1 wt .-% solution of the polymer in water has a viscosity of 1500 mPa s or lower and a transmission of 90% or higher, and this solution with an addition of 0.25 to 5 parts by weight NaCl to 100 parts by weight of this Solution has a highest viscosity of 15,000 to 40,000 mPa s and a transmission of 90% or higher,
ist. is.
In einer alternativen bevorzugten Ausführungsform enthält die erfindungsgemäße Formulierung eine Komponente A), die mindestens ein alkylmodifizierte In an alternative preferred embodiment, the formulation of the invention contains a component A) containing at least one alkyl-modified
Carboxylgruppen aufweisendes, wasserlösliches Copolymer, welches erhältlich ist durch Polymerisation von Carboxyl-containing, water-soluble copolymer which is obtainable by polymerization of
100 Gewichtsteilen Acryl- oder Methacrylsäure, 100 parts by weight of acrylic or methacrylic acid,
5 bis 10, bevorzugt 6 bis 9,1 , Gewichtsteilen Lauryl-Acrylat oder Lauryl-Methacrylat und  5 to 10, preferably 6 to 9.1, parts by weight of lauryl acrylate or lauryl methacrylate and
0 bis 0,1 , bevorzugt 0,001 bis 0,1 , besonders bevorzugt 0,001 bis 0,044, 0 to 0.1, preferably 0.001 to 0.1, particularly preferably 0.001 to 0.044,
Gewichtsteilen einer Substanz enthaltend zwei oder mehr ethylenisch ungesättigte Reste,  Parts by weight of a substance containing two or more ethylenically unsaturated radicals,
wobei eine neutralisierte, 1 gew.-%ige Lösung des Polymers in Wasser eine Viskosität von 1000 mPa s oder niedriger und eine Transmission von 95 % oder höher aufweist und diese Lösung bei einer Zugabe von 1 bis 7 Gewichtsteilen NaCI auf 100 wherein a neutralized, 1 wt .-% solution of the polymer in water has a viscosity of 1000 mPa s or lower and a transmission of 95% or higher, and this solution with an addition of 1 to 7 parts by weight NaCl to 100
Gewichtsteile dieser Lösung eine höchste Viskosität von 10000 bis 30000 mPa s und eine Transmission von 95 % oder höher aufweist,  Parts by weight of this solution has a highest viscosity of 10,000 to 30,000 mPa s and a transmission of 95% or higher,
ist. Die erfindungsgemäß in den Formulierungen enthaltenen Copolymere lassen sich nach an sich bekannten Verfahren herstellen, eine detaillierte Verfahrensbeschreibung zur Herstellung der erfindungsgemäß enthaltenen Copolymere ist in EP1953176 und EP 1950231 beschrieben. is. The copolymers according to the invention contained in the formulations can be prepared by processes known per se, a detailed process description for the preparation of the copolymers according to the invention is described in EP1953176 and EP 1950231.
Kommerziell erhältliche Polymere tragen beispielsweise den Namen TEGO® Carbomer SER 841 (Evonik Industries), Aqupec SER W150C und Aqupec SER W300C Commercially available polymers carry, for example, the name TEGO Carbomer ® SER 841 (Evonik Industries), Aqupec SER SER Aqupec W150C and W300C
(Sumitomo Seika) Erfindungsgemäß bevorzugte Formulierungen sind dadurch gekennzeichnet, dass die Substanz enthaltend zwei oder mehr ethylenisch ungesättigte Reste ausgewählt ist aus der Gruppe bestehend aus Pentaerythritol Allyl Ether, Diethylen Glycol Diallyl Ether, Polyethylen Glycol Diallyl Ether und Polyallyl Saccharose. (Sumitomo Seika) Preferred formulations according to the invention are characterized in that the substance containing two or more ethylenically unsaturated radicals is selected from the group consisting of pentaerythritol allyl ether, diethylene glycol diallyl ether, polyethylene glycol diallyl ether and polyallyl sucrose.
Der Anteil der Komponente A) an der erfindungsgemäßen Formulierung beträgt vorzugsweise von 0,01 bis 10 Gew.-%, bevorzugt von 0,1 bis 5 Gew.-% und besonders bevorzugt von 0,5 bis 3 Gew.-% bezogen auf die Gesamtformulierung. The proportion of component A) in the formulation according to the invention is preferably from 0.01 to 10 wt .-%, preferably from 0.1 to 5 wt .-% and particularly preferably from 0.5 to 3 wt .-% based on the total formulation.
Der Anteil der Komponente B) an der erfindungsgemäßen Formulierung beträgt vorzugsweise von 0,1 bis 30 Gew.-%, bevorzugt von 1 bis 20 Gew.-% und besonders bevorzugt von 2 bis 10 Gew.-% bezogen auf die Gesamtformulierung. The proportion of component B) in the formulation according to the invention is preferably from 0.1 to 30 wt .-%, preferably from 1 to 20 wt .-% and particularly preferably from 2 to 10 wt .-% based on the total formulation.
Die erfindungsgemäßen Formulierungen können als Komponente B) Sulfosuccinate enthalten. Diese umfassen die Salze der Alkylsulfobernsteinsäure, die auch als Sulfobernsteinsäureester bezeichnet werden und die Monoester und/oder Diester der Sulfobernsteinsäure mit Alkoholen, vorzugsweise Fettalkoholen und insbesondere ethoxylierten Fettalkoholen umfassen. Bevorzugte Sulfosuccinate enthalten C8-C18- Fettalkoholreste oder Mischungen aus diesen. Insbesondere bevorzugte The formulations according to the invention may contain sulfosuccinates as component B). These include the salts of alkylsulfosuccinic acid, also referred to as sulfosuccinic acid esters, which include monoesters and / or diesters of sulfosuccinic acid with alcohols, preferably fatty alcohols and in particular ethoxylated fatty alcohols. Preferred sulfosuccinates contain C8-C18 fatty alcohol residues or mixtures of these. Especially preferred
Sulfosuccinate enthalten einen Fettalkoholrest, der sich von ethoxylierten Fettalkoholen ableitet. Dabei sind wiederum Sulfosuccinate, deren Fettalkohol-Reste sich von ethoxylierten Fettalkoholen mit enger Homologenverteilung ableiten, besonders bevorzugt. Ebenso ist es auch möglich, Alk(en)ylbernsteinsäure mit vorzugsweise 8 bis 18 Kohlenstoffatomen in der AI k(en)yl kette oder deren Salze einzusetzen. Besonders bevorzugte Sulfosuccinate sind PEG- und sulfat-frei. Beispiele für solche PEG- und sulfatfreien Sulfosuccinate sind die Monosulfosuccinate von Polyglyceryl-6-cocoat, Polyglyceryl-4-caprat, Polyglyceryl-4-caprylat, Polyglyceryl-3-caprat oder Polyglyceryl- 3-caprylat sowie Mischungen davon. Besonders bevorzugte PEG- und sulfat-freie Sulfosuccinate und deren Herstellung sind in der PCT/EP2013/050367 beschrieben. Sulfosuccinates contain a fatty alcohol residue derived from ethoxylated fatty alcohols. Sulfosuccinates, whose fatty alcohol residues are derived from ethoxylated fatty alcohols with a narrow homolog distribution, are again particularly preferred. Likewise, it is also possible to use alk (en) ylsuccinic acid having preferably 8 to 18 carbon atoms in the Al k (en) yl chain or salts thereof. Particularly preferred sulfosuccinates are PEG and sulfate free. Examples of such PEG and sulfate-free sulfosuccinates are the monosulfosuccinates of polyglyceryl-6-cocoate, polyglyceryl-4-caprate, polyglyceryl-4-caprylate, polyglyceryl-3-caprate or polyglyceryl-3-caprylate and mixtures thereof. Particularly preferred PEG and sulfate-free sulfosuccinates and their preparation are described in PCT / EP2013 / 050367.
Bevorzugt weist die erfindungsgemäße Formulierung als Komponente B)„Biotensid" Rhamnolipide, Sophorolipide, Glucoselipide, Celluloselipide und/oder Trehaloselipide, bevorzugt Rhamnolipide und/oder Sophorolipide auf. Die Biotenside, insbesondere Glykolipidtenside können z. B. wie in EP 0 499 434, US 7,985 722, WO 03/006146, JP 60-183032, DE 19648439, DE 19600743, JP 01-304034, CN 1337439, JP 2006- 274233, KR 2004033376, JP 2006-083238, JP 2006-070231 , WO 03/002700, FR 2740779, DE 2939519, US 7,556,654, FR 2855752, EP 1445302, JP 2008-062179 und JP 2007-181789 oder den dort zitierten Schriften hergestellt werden. Geeignete Biotenside können z. B. von der Firma Soliance, France bezogen werden. The formulation according to the invention preferably comprises as component B) "biosurfactant" rhamnolipids, sophorolipids, glucoselipids, celluloselipids and / or trehaloselipids, preferably rhamnolipids and / or sophorolipids The biosurfactants, in particular glycolipid surfactants, can be obtained, for example, as described in EP 0 499 434, US Pat 7,985,722, WO 03/006146, JP 60-183032, DE 19648439, DE 19600743, JP 01-304034, CN 1337439, JP 2006- 274233, KR 2004033376, JP 2006-083238, JP 2006-070231, WO 03/002700, FR 2740779, DE 2939519, US 7,556,654, FR 2855752, EP 1445302, JP 2008-062179 and JP 2007-181789 or the publications cited therein become. Suitable biosurfactants may, for. B. from the company Soliance, France.
Bevorzugt weist die erfindungsgemäße Formulierung als Biotenside Rhamnolipide, insbesondere Mono-, Di- oder Polyrhamnolipide und/oder Sophorolipide auf. Besonders bevorzugt weist die erfindungsgemäße Formulierung eines oder mehrere der in EP 1 445 302 A mit den Formeln (I), (II) bzw. (III) beschriebenen Rhamnolipide bzw. Sophorolipide auf. The formulation according to the invention preferably has rhamnolipids as biosurfactants, in particular mono-, di- or poly-pyrnolipids and / or sophorolipids. The formulation according to the invention particularly preferably has one or more of the rhamnolipids or sophorolipids described in EP 1 445 302 A with the formulas (I), (II) or (III).
Eine bevorzugte erfindungsgemäße Formulierung ist dadurch gekennzeichnet, dass sie eine zusätzliche Komponente C) enthält, welche auswählt ist aus der Gruppe der ammonium-, phosphonium-, imidazolinium- oder imidazoliumgruppenhaltigen A preferred formulation according to the invention is characterized in that it contains an additional component C), which is selected from the group of ammonium, phosphonium, imidazolinium or imidazoliumgruppenhaltigen
Verbindungen, bevorzugt quaternierte ammoniumgruppenhaltige Verbindungen, besonders bevorzugt Alkylquats, wie z.B. Cetrimonium Chloride (VARISOFT® 300), Dialkylquats oder Esterquats, oder aus der Gruppe der kationischen Polymere, bevorzugt kationisches Guar, kationische Siloxane, und Polyquaternium Verbindungen, insbesondere Polyquaternium 1 bis Polyquaternium 94, besonders bevorzugt Compounds, preferably quaternized ammonium group-containing compounds, particularly preferably alkyl quats, such as Cetrimonium Chloride (VARISOFT ® 300), dialkyl quats or esterquats, or from the group of cationic polymers, preferably cationic guar, cationic siloxanes, and Polyquaternium compounds, in particular Polyquaternium 1 to Polyquaternium 94th , especially preferred
Hydroxypropyl guar hydroxypropyltrimonium Chloride, Polyquaternium 7, Hydroxypropyl guar hydroxypropyltrimonium chlorides, Polyquaternium 7,
Polyquaternium 10 und Polyquaternium 1 1 , und Silicone Quaternium-22 (ABIL® T Quat 60 und ABIL ME 45). Polyquaternium 10 and Polyquaternium 1 1, and Silicone Quaternium-22 (ABIL Quat ® T 60 and ABIL ME 45).
Der Begriff„ammonium-, phosphonium-, imidazolinium- oder  The term "ammonium, phosphonium, imidazolinium or
imidazoliumgruppenhaltige Verbindung" im Zusammenhang mit der vorliegenden Erfindung schließt Verbindungen mit ein, die unter den Bedingungen der gegebenen Formulierung, beispielsweise aufgrund des pH-Wertes, überwiegend an der imidazolium group-containing compound "in the context of the present invention includes compounds which, under the conditions of the given formulation, for example due to the pH, predominantly on the
vorgenannten Gruppe ein Proton aufweisen und somit kationisch geladen sind. Solche Substanzen sind bevorzugt auswählt aus der Gruppe der Aminosiloxane, besonders bevorzugt Aminopropyl Dimethicone (ABIL Soft AF 200) oder Amodimethicone. aforementioned group have a proton and are thus cationically charged. Such substances are preferably selected from the group of aminosiloxanes, particularly preferably aminopropyl dimethicones (ABIL Soft AF 200) or amodimethicones.
Der Anteil der Komponente C) an der erfindungsgemäßen Formulierung beträgt vorzugsweise von 0,05 bis 30 Gew.-%, bevorzugt von 0,2 bis 20 Gew.-% und besonders bevorzugt von 0,5 bis 10 Gew.-% bezogen auf die Gesamtformulierung. Insbesondere erfindungsgemäße Formulierungen sind bevorzugt, die im Wesentlichen frei von alkoxylierten Verbindungen sind. Unter dem Begriff„im Wesentlichen frei von alkoxylierten Verbindungen" im Zusammenhang mit der vorliegenden Erfindung ist zu verstehen, dass die Formulierungen keine nennenswerten Mengen an alkoxylierten Verbindungen aufweist, die eine oberflächenaktive Wirkung ausüben. Insbesondere ist hierunter zu verstehen, dass diese Verbindungen in Mengen von kleiner 1 Gew.-%, bevorzugt von kleiner 0,1 Gew.-%, besonders bevorzugt von kleiner 0,01 Gew.-% bezogen auf die Gesamtformulierung, insbesondere keine nachweisbaren Mengen, enthalten sind. The proportion of component C) in the formulation according to the invention is preferably from 0.05 to 30 wt .-%, preferably from 0.2 to 20 wt .-% and particularly preferably from 0.5 to 10 wt .-% based on the total formulation. In particular, formulations according to the invention are preferred which are substantially free of alkoxylated compounds. By the term "essentially free of alkoxylated compounds "in the context of the present invention, it is to be understood that the formulations do not contain appreciable amounts of alkoxylated compounds which exert a surface-active action, in particular by the fact that these compounds are present in amounts of less than 1% by weight of less than 0.1% by weight, more preferably less than 0.01% by weight, based on the total formulation, in particular no detectable amounts.
Insbesondere erfindungsgemäße Formulierungen sind bevorzugt, die im Wesentlichen frei von Sulfaten sind. Unter dem Begriff„im Wesentlichen sulfatfrei" im In particular, formulations according to the invention are preferred which are substantially free of sulphates. By the term "substantially sulphate-free" in the
Zusammenhang mit der vorliegenden Erfindung ist zu verstehen, dass die In connection with the present invention, it should be understood that the
Formulierungen keine nennenswerten Mengen an sulfatierten organischen Formulations no appreciable amounts of sulfated organic
Verbindungen aufweisen, die eine oberflächenaktive Wirkung ausüben. Insbesondere ist hierunter zu verstehen, dass sulfatierte organische Verbindungen in Mengen von kleiner 1 Gew.-%, bevorzugt von kleiner 0,1 Gew.-%, besonders bevorzugt von kleiner 0,01 Gew.-% bezogen auf die Gesamtformulierung, insbesondere keine Have compounds that exert a surface-active effect. In particular, this is understood to mean that sulfated organic compounds in amounts of less than 1 wt .-%, preferably less than 0.1 wt .-%, particularly preferably less than 0.01 wt .-% based on the total formulation, in particular no
nachweisbaren Mengen, enthalten sind. Beispiele für sulfathaltige Tenside stellen Sodium Laureth Sulfate, Sodium Lauryl Sulfate, Ammonium Laureth Sulfate, detectable amounts are included. Examples of sulphate-containing surfactants are sodium laureth sulphates, sodium lauryl sulphates, ammonium laureth sulphates,
Ammonium Lauryl Sulfate, Sodium Myreth Sulfate, Sodium Coco Sulfate, Sodium Trideceth Sulfate oder MIPA-Laureth Sulfate dar. Ammonium Lauryl Sulfate, Sodium Myreth Sulfate, Sodium Coco Sulfate, Sodium Trideceth Sulfate or MIPA-Laureth Sulfate.
Ganz besonders bevorzugte erfindungsgemäße Formulierungen sind im Wesentlichen sulfatfrei und Wesentlichen frei von alkoxylierten Verbindungen. Ein weiterer Gegenstand der vorliegenden Erfindung ist die Verwendung der oben als Komponente A) definierten Copolymere zur Verdickung von kosmetischen Very particularly preferred formulations according to the invention are essentially sulfate-free and substantially free of alkoxylated compounds. Another object of the present invention is the use of the copolymers defined above as component A) for the thickening of cosmetic
Formulierungen enthaltend mindestens ein Tensid ausgewählt aus der Gruppe bestehend aus Sulfosuccinate und Biotenside. Formulations containing at least one surfactant selected from the group consisting of sulfosuccinates and biosurfactants.
Bevorzugte erfindungsgemäße Verwendung verwendet die oben als bevorzugt genannten Komponenten A). Analoges gilt für die im Rahmen der Verwendung zu verdickenden Formulierungen.  Preferred use according to the invention uses the components A) mentioned above as preferred. The same applies to the formulations to be thickened in the context of use.
In den nachfolgend aufgeführten Beispielen wird die vorliegende Erfindung beispielhaft beschrieben, ohne dass die Erfindung, deren Anwendungsbreite sich aus der gesamten Beschreibung und den Ansprüchen ergibt, auf die in den Beispielen genannten Ausführungsformen beschränkt sein soll. Beispiele: In the examples given below, the present invention is described by way of example, without the invention, the scope of application of which is apparent from the entire description and the claims, to be limited to the embodiments mentioned in the examples. Examples:
In den Tabellen angegebene Werte sind Gew.-% bezogen auf Gesamtformulierung. Values given in the tables are% by weight based on the total formulation.
Verdi ckungswirkung von TEGO® Carbomer SER 841 auf schwer verdickbare sulfosuccinat- und/oder biotensidh altige Formulierungen Thickening effect of TEGO ® Carbomer SER 841 on difficult to thicken sulfosuccinate and / or biosurfactant formulations
Die Messwerte der folgenden Tabelle zeigen, dass TEGO® Carbomer SER 841 in der Lage ist, entsprechende Formulierungen mit geringerer Salzbelastung in der The measurements in the following table show that TEGO ® Carbomer SER 841 is able to provide corresponding formulations with lower salt load in the
Formulierung zu verdicken, wohingegen Novethix ® L-10(INCI: Acrylates/Beheneth-25 Methacrylate Copolymer, [Novethix™ L-10 Polymer] manufactured by Lubrizol Advanced Materials, Inc.) entweder viel zusätzliches Salz benötigt, oder gar keine verdickende Wirkung zeigt. To thicken the formulation, whereas Novethix ® L-10 (INCI: Acrylates Beheneth-25 Methacrylate Copolymer [Novethix ™ L-10 polymer] manufactured by Lubrizol Advanced Materials, Inc. /) requires either a lot of additional salt, or no thickening effect shows ,
TEGO® Carbomer SER Novethix ® L-10 841 (Acrylates/Beheneth-25 TEGO Carbomer ® SER Novethix ® L-10 841 (Acrylates / Beheneth-25
Methacrylate  methacrylates
Copolymer)  copolymer)
PEG- free System 1  PEG-free system 1
4,8% REWOTERIC® AM C, 32% 4.8% REWOTERIC AM ® C, 32%
(Sodium Cocoamphoacetate) 3040 mPas (Sodium Cocoamphoacetate) 3040 mPas
nicht verdickbar not thickenable
4,8% CAPB, 38% 0,3 % NaCI 4.8% CAPB, 38% 0.3% NaCl
1 % Polymer (Cocamidopropyl Betaine) 1 % Carbomer  1% polymer (cocamidopropyl betaine) 1% carbomer
3,6% REWOPOL® SB F 12P, 95% 3.6% REWOPOL ® SB F 12P, 95%
(Disodium Lauryl Sulfosuccinate) (Disodium Lauryl Sulfosuccinate)
PEG-free System2 PEG-free system2
5,6% REWOTERIC® AM C, 32% 5.6% REWOTERIC ® AM C, 32%
(Sodium Cocoamphoacetate) 3170 mPas 3210 mPas(Sodium Cocoamphoacetate) 3170 mPas 3210 mPas
4,4% Lauryl Glucoside, 50% 1 ,5 % NaCI 4,2 % NaCI4.4% lauryl glucoside, 50% 1, 5% NaCl 4.2% NaCl
1 ,2% Coco Glucoside, 50% 0,1 % Carbomer 0,1 % Polymer1.2% Coco Glucoside, 50% 0.1% Carbomer 0.1% Polymer
3,6% Sodium Disodium Cocoyl 3.6% sodium disodium cocoyl
Glutamate, 25% PEG-free System3 Glutamate, 25% PEG-free system3
5,6% CAPB, 38%  5.6% CAPB, 38%
4100 mPas 1710 mPas 4100 mPas 1710 mPas
4,4% Lauryl Glucoside, 50% 4.4% lauryl glucoside, 50%
0 % NaCI 2 % NaCI 0% NaCl 2% NaCl
1 ,2% Coco Glucoside, 50% 1, 2% Coco Glucoside, 50%
0,3 % Carbomer 0,3 % Polymer 0.3% carbomer 0.3% polymer
3,6% REWOPOL® SB F 12P, 95% 3.6% REWOPOL ® SB F 12P, 95%
(Disodium Lauryl Sulfosuccinate)  (Disodium Lauryl Sulfosuccinate)
Verdickungswirkung von TEGO® Carbomer SER 841 auf schwer verdickbare sulfosuccinat- und biotensidhaltige Formulierungen mit positiv geladenen Polymeren Thickening effect of TEGO ® Carbomer SER 841 on difficult-to-thicken sulfosuccinate- and biosurfactant-containing formulations with positively charged polymers
Die folgende Tabelle zeigt, dass Guar-Quat und Polyquaternium 10 die Verdickung einer sulfosuccinat- und biotensidhaltigen Formulierung durch das Carbomer zusätzlich verstärkt. The following table shows that guar-quat and polyquaternium 10 additionally enhance the thickening of a sulfosuccinate and biosurfactant formulation by the carbomer.
1 2 3 4 51 2 3 4 5
Lauryl Glucoside, 50% 8.80 8.80 8.80 8.80 8.80Lauryl Glucoside, 50% 8.80 8.80 8.80 8.80 8.80
Coco Glucoside, 50% 2.30 2.30 2.30 2.30 2.30Coco Glucoside, 50% 2.30 2.30 2.30 2.30 2.30
REWOPOL® SB F 12P, 95% REWOPOL ® SB F 12 P, 95%
(Disodium Lauryl 3.80 3.80 3.80 3.80 3.80 Sulfosuccinate) (Disodium Lauryl 3.80 3.80 3.80 3.80 3.80 Sulfosuccinates)
TEGO® Betain F 50; 38% TEGO ® betaine F 50; 38%
14.70 14.70 14.70 14.70 14.70 (Cocamidopropyl Betaine)  14.70 14.70 14.70 14.70 14.70 (Cocamidopropyl Betaine)
Hydroxypropyl guar  Hydroxypropyl guar
hydroxypropyltrimonium 0.5 0.75 1 hydroxypropyltrimonium 0.5 0.75 1
Chloride  Chloride
Polyquaternium- 10 1 Polyquaternium 10 1
TEGO® Carbomer 841 SER 0.3 0.3 0.3 0.3 0.3TEGO ® Carbomer 841 SER 0.3 0.3 0.3 0.3 0.3
Water 70.1 69.6 69.35 69.1 69.1Water 70.1 69.6 69.35 69.1 69.1
Viscosity 5019 6837 8400 8900 5729 pH 5.7 5.7 5.7 5.7 5.7 Beispielform ulierungen : Viscosity 5019 6837 8400 8900 5729 pH 5.7 5.7 5.7 5.7 5.7 Example formations:
Mild Hair & Body Shampoo; PEG- and sulfate- free Mild Hair & Body Shampoo; PEG and sulfate free
REWGTERIC® AM C, 32% (Sodium REWGTERIC ® AM C, 32% (Sodium
27.30 % Cocoamphoacetate)  27.30% cocoamphoacetate)
ANTIL® SPA 80 (Isostearamide MI PA; ANTIL ® SPA 80 (Isostearamide MI PA;
1.50 % Glyceryl Laurate)  1.50% glyceryl laurate)
Water 64.50 % Water 64.50%
TEGO® Carbomer 841 SER 1.00 %TEGO Carbomer ® 841 1:00 SER%
Sophorolipid (säureform) 3.20 %Sophorolipid (acid form) 3.20%
NaCI 1.50 %NaCl 1.50%
Preservative (Neolone PE) 0.45 %Preservative (Neolone PE) 0.45%
Perfume (Powder Fruit) 0.25 %Perfume (Powder Fruit) 0.25%
Citric Acid (30% ig) 1.50 % Citric Acid (30%) 1.50%
Mild Hair & Body Shampoo; PEG-, Sulfate- and Betaine- freeMild Hair & Body Shampoo; PEG, sulphate and betaine-free
Plantacare 1200 UP, 50% (Lauryl Plantacare 1200 UP, 50% (Lauryl
8.80 % Glucoside)  8.80% glucosides)
ANTIL® Soft SC (Sorbitan ANTIL ® Soft SC (Sorbitan
0.60 % Sesquicaprylate)  0.60% sesquicaprylates)
Water 53.10 % Water 53.10%
TEGO® Carbomer 841 SER 0.50 %TEGO ® Carbomer 841 SER 0.50%
Plantacare 818 UP, 50% (Coco Glucoside) 2.40 %Plantacare 818 UP, 50% (Coco Glucoside) 2.40%
Sodium/ Disodium Cocoyl Glutamate; 25% 14.40 %Sodium / disodium cocoyl glutamate; 25% 14.40%
REWOTERIC® AM C, 32% (Sodium REWOTERIC ® AM C, 32% (Sodium
17.50 % Cocoamphoacetate)  17.50% cocoamphoacetate)
Perfume (Powder Fruit) 0.25 % Perfume (Powder Fruit) 0.25%
Preservative (Neolone PE) 0.45 %Preservative (Neolone PE) 0.45%
Citric Acid (30%) 2.00 % Mild Hair & Body Shampoo; PEG- and sulfate- free Citric Acid (30%) 2.00% Mild Hair & Body Shampoo; PEG and sulfate free
Plantacare 1200 UP, 50% (Lauryl  Plantacare 1200 UP, 50% (Lauryl
1 1.70 % Glucoside)  1 1.70% glucosides)
ANTIL® Soft SC (Sorbitan ANTIL ® Soft SC (Sorbitan
0.50 % Sesquicaprylate)  0.50% sesquicaprylate)
Water 63.00 % Water 63.00%
TEGO® Carbomer 841 SER 0.50 %TEGO ® Carbomer 841 SER 0.50%
Plantacare 818 UP, 50% (Coco Plantacare 818 UP, 50% (Coco
5.60 % Glucoside)  5.60% glucosides)
TEGO® Betain F 50, 38% TEGO ® Betain F 50, 38%
18.00 % (Cocamidopropyl Betaine)  18.00% (cocamidopropyl betaine)
Preservative (Neolone PE) 0.45 % Preservative (Neolone PE) 0.45%
Perfume (Powder Fruit) 0.25 % Perfume (Powder Fruit) 0.25%
PEG-, Sulfate- and Betaine- free Conditioning Shampoo PEG, sulphate and betaine free conditioning shampoo
REWGTERIC® AM C, 32% (Sodium REWGTERIC ® AM C, 32% (Sodium
27.30 % Cocoamphoacetate)  27.30% cocoamphoacetate)
ANTIL® SPA 80 (Isostearamide MI PA; ANTIL ® SPA 80 (Isostearamide MI PA;
1 .00 % Glyceryl Laurate)  1 .00% glyceryl laurate)
Water 64.30 % Water 64.30%
TEGO® Carbomer 841 SER 0.50 %TEGO ® Carbomer 841 SER 0.50%
Disodium Polyglyceryl-3 Caprate/ Disodium Polyglyceryl-3 Caprate /
3.20 % Caprylate Sulfosuccinate  3.20% Caprylate Sulfosuccinate
Preservative (Neolone PE) 0.45 % Preservative (Neolone PE) 0.45%
Perfume (Powder Fruit) 0.25 %Perfume (Powder Fruit) 0.25%
Citric Acid (30%) 3.00 % Citric Acid (30%) 3.00%
Weitere Formulierungen: Further formulations:
Mild Hair & Body Shampoo; PEG- and Sulfate- free  Mild Hair & Body Shampoo; PEG and sulfate free
Mild Hair & Body Shampoo; PEG- and Sulfate- free Mild Hair & Body Shampoo; PEG and sulfate free
TEGO® Carbomer 841 SER 1 ,10 %TEGO ® Carbomer 841 SER 1, 10%
Water 73,9 %Water 73.9%
Disodium Polyglyceryl-3 Caprate/ Disodium Polyglyceryl-3 Caprate /
8,3 % Caprylate Sulfosuccinate  8.3% Caprylate Sulfosuccinate
REWOTERIC® AM C; 32% (Sodium REWOTERIC AM ® C; 32% (Sodium
15,6 % Cocoamphoacetate)  15.6% cocoamphoacetate)
P reservat! ve 0,45 % P reservation! 0.45%
Perfume 0,25 % Perfume 0.25%
Mild Hair & Body Shampoo; PEG- and Sulfate- free Mild Hair & Body Shampoo; PEG and sulfate free
TEGO® Carbomer 841 SER 0,50 %TEGO Carbomer ® 841 SER 0.50%
Water 74,9 %Water 74.9%
Sodium Lauroyl Methyl Isethionate; 32% 6,25 %Sodium lauroyl methyl isethionate; 32% 6.25%
Disodium Polyglyceryl-3 Caprate/ Disodium Polyglyceryl-3 Caprate /
8,30 % Caprylate Sulfosuccinate  8.30% Caprylate Sulfosuccinate
REWOTERIC® AM C; 32% (Sodium REWOTERIC AM ® C; 32% (Sodium
9,30 % Cocoamphoacetate)  9.30% cocoamphoacetate)
P reservat! ve 0,45 % P reservation! 0.45%
Perfume 0,25 % Perfume 0.25%
Mild Hair & Body Shampoo; PEG- and Sulfate- free Mild Hair & Body Shampoo; PEG and sulfate free
TEGO® Carbomer 841 SER 1 ,50 %TEGO ® Carbomer 841 SER 1, 50%
Water 74,1 %Water 74.1%
TEGO® Betain 810; 35,5% TEGO ® betaine 810; 35.5%
2,90 % (Capryl/Capramidopropyl Betaine)  2.90% (caprylic / capramidopropyl betaine)
Disodium Polyglyceryl-3 Caprate/  Disodium Polyglyceryl-3 Caprate /
8,30 % Caprylate Sulfosuccinate  8.30% Caprylate Sulfosuccinate
REWOTERIC® AM C; 32% (Sodium REWOTERIC AM ® C; 32% (Sodium
12,50 % Cocoamphoacetate)  12.50% cocoamphoacetate)
P reservat! ve 0,45 % P reservation! 0.45%
Perfume 0,25 % Perfume 0.25%
Body Wash Body wash
TEGO® Carbomer 841 SER 0,20 %TEGO Carbomer ® 841 SER 0.20%
Water 78,90 %Water 78.90%
Sodium Lauroyl Sarcosinate (30%) 10,00 %Sodium lauroyl sarcosinate (30%) 10.00%
TEGO® Betain F 50; 38% TEGO ® betaine F 50; 38%
10,00 % (Cocamidopropyl Betaine)  10.00% (cocamidopropyl betaine)
Lactic Acid 0,20 % Lactic Acid 0.20%
Formic Acid 0,70 % Mild Hair & Body Shampoo Formic Acid 0.70% Mild Hair & Body Shampoo
Mild Hair & Body Shampoo Mild Hair & Body Shampoo
REWOTERIC® AM C; 32% (Sodium REWOTERIC AM ® C; 32% (Sodium
15,00 % Cocoamphoacetate)  15.00% cocoamphoacetate)
ANTIL® Soft SC (Sorbitan ANTIL ® Soft SC (Sorbitan
0,90 % Sesquicaprylate)  0.90% sesquicaprylate)
Perfume 0,25 % Perfume 0.25%
Water 66,20 %Water 66.20%
TEGO® Carbomer 841 SER 1 ,00 %TEGO Carbomer ® 841 SER 1, 00%
Rhamnolipid 3,20 %Rhamnolipid 3.20%
TEGO® Betain F 50; 38% TEGO ® betaine F 50; 38%
13,00 % (Cocamidopropyl Betaine)  13.00% (cocamidopropyl betaine)
Preservative (Neolone PE) 0,45 % Preservative (Neolone PE) 0.45%
Mild Intimate Wash Gel Mild Intimate Wash Gel
Mild Intimate Wash Gel Mild Intimate Wash Gel
Water 84,7 % Water 84.7%
TEGO® Carbomer 841 SER 1 ,10 %TEGO ® Carbomer 841 SER 1, 10%
Disodium Polyglyceryl-3 Caprate/ Disodium Polyglyceryl-3 Caprate /
3,70 % Caprylate Sulfosuccinate  3.70% Caprylate Sulfosuccinate
REWOTERIC® AM B U 185; 30% REWOTERIC ® AM BU 185; 30%
4,00 % (Undecylenamidopropyl Betaine)  4.00% (undecylenamidopropyl betaine)
TEGO® Betain 810; 35,5% TEGO ® betaine 810; 35.5%
2,00 % (Capryl/Capramidopropyl Betaine)  2.00% (caprylic / capramidopropyl betaine)
LACTIL® (Sodium Lactate; Sodium PCA; LACTIL ® (Sodium Lactate, Sodium PCA;
Glycine; Fructose; Urea; Niacinamide; 1 ,00 % Inositol; Sodium Benzoate; Lactic Acid)  Glycine; fructose; Urea; Niacinamide; 1.00% inositol; Sodium benzoate; Lactic acid)
Glycerin 3,00 % Glycerin 3.00%
NaOH (50%) 0,50 %NaOH (50%) 0.50%
Preservative, Perfume q.s. Creamy Anti-Dandruff Shampoo Preservative, perfume qs Creamy anti-dandruff shampoo
Mild Shampoo Mild shampoo
Sodium Laureth Sulfate, 28% 21 ,00 % Sodium Laureth Sulfate, 28% 21, 00%
Water 61 ,30 %Water 61, 30%
TEGO® Carbomer 841 SER 0,80%TEGO Carbomer ® 841 SER 0.80%
REWOPOL® SB FA 30 B; 40% (Disodium REWOPOL ® SB FA 30 B; 40% (Disodium
6,00 % Laureth Sulfosuccinate)  6.00% Laureth Sulfosuccinate)
TEGOSOFT® LSE 65 K SOFT (Sucrose TEGOSOFT ® LSE 65 K SOFT (sucrose
2,50 % Cocoate)  2.50% Cocoate)
TEGO® Betain C 60; 47% TEGO ® C 60 betaine; 47%
5,90 % (Cocamidopropyl Betaine)  5.90% (cocamidopropyl betaine)
VARISOFT® PATC VARISOFT ® PATC
2,50 % 2.50%
(Palmitamidopropyltrimonium Chloride) (Palmitamidopropyltrimonium Chloride)
Preservative, Perfume q.s. Body Wash Preservative, perfume qs Body wash
ABI L® Quat 3272; 50% (Quaternium-80) 0,60 %ABI Quat 3272; 50% (Quaternium-80) 0.60%
TAGAT® CH 40 (PEG-40 Hydrogenated TAGAT ® CH (40 PEG-40 Hydrogenated
0,50 % Caster Oil)  0.50% caster oil)
Perfume 0,30% Perfume 0.30%
TEGO® Betain 810; 35,5 TEGO ® betaine 810; 35.5
2,00 % (Capryl/Capramidopropyl Betaine)  2.00% (caprylic / capramidopropyl betaine)
Disodium Polyglyceryl-3 Caprate/  Disodium Polyglyceryl-3 Caprate /
2,00% Caprylate Sulfosuccinate  2.00% Caprylate Sulfosuccinate
Water 91 ,00 % Water 91, 00%
TEGO® Carbomer 841 SER 1 ,00 %TEGO Carbomer ® 841 SER 1, 00%
TEGO® Cosmo C 100 (Creatine) 0,50 %TEGO ® Cosmo C 100 (Creatine) 0.50%
TEGOCEL® HPM 50 (Hydroxypropyl TEGOCEL ® HPM 50 (Hydroxypropyl
0,30 % Methylcellulose)  0.30% methyl cellulose)
VARISOFT® 300; 30% (Cetrimonium VARISOFT ® 300; 30% (Cetrimonium
1 ,30 % Chloride)  1, 30% chlorides)
LACTIL® (Sodium Lactate; Sodium PCA; LACTIL ® (Sodium Lactate, Sodium PCA;
Glycine; Fructose; Urea; Niacinamide; 0,50 % Inositol; Sodium Benzoate; Lactic Acid) Glycine; fructose; Urea; Niacinamide; 0.50% inositol; Sodium benzoate; Lactic acid)
Preservative, Perfume q.s.  Preservative, Perfume q.s.
Mild Babyshampoo Mild baby shampoo
REWOTERIC® AM C; 32% (Sodium REWOTERIC AM ® C; 32% (Sodium
10,00 % Cocoamphoacetate)  10.00% cocoamphoacetate)
Disodium Polyglyceryl-3 Caprate/  Disodium Polyglyceryl-3 Caprate /
5,00 % Caprylate Sulfosuccinate  5.00% Caprylate Sulfosuccinate
REWOPOL® SB FA 30 B; 40% (Disodium REWOPOL ® SB FA 30 B; 40% (Disodium
10,00 % Laureth Sulfosuccinate)  10.00% Laureth Sulfosuccinate)
TEGOSOFT® GC (PEG-7 Glyceryl TEGOSOFT ® GC (PEG-7 Glyceryl
0,50 % Cocoate)  0.50% Cocoate)
REWOMI D® IPP 240 (Cocamide MIPA) 0,50 %REWOMI D ® IPP 240 (Cocamide MIPA) 0.50%
VARISOFT® PATC VARISOFT ® PATC
2,50 % 2.50%
(Palmitamidopropyltrimonium Chloride) (Palmitamidopropyltrimonium Chloride)
Water 70,00 % TEGO® Carbomer 841 SER 1 ,50 %Water 70.00% TEGO ® Carbomer 841 SER 1, 50%
Preservative, Perfume q.s. Preservative, Perfume q.s.
Body Wash Body wash
Sodium laureth sulfate; 28% 21 ,5 % Sodium laureth sulfate; 28% 21, 5%
Rhamnolipid; 76,9% 8,0 %rhamnolipid; 76.9% 8.0%
TEGO® Carbomer 841 SER 1 ,0 %TEGO Carbomer ® 841 SER 1, 0%
Sodium Chloride 2,5 %Sodium Chloride 2.5%
Water 67,0 %Water 67.0%
Preservative, Perfume q.s. Body Wash Preservative, perfume qs Body wash
Sodium laureth sulfate; 28% 10,5 % Sodium laureth sulfate; 28% 10.5%
Rhamnolipid; 76,9% 1 1 ,5 %rhamnolipid; 76.9% 1 1, 5%
TEGO® Carbomer 841 SER 1 ,0 %TEGO Carbomer ® 841 SER 1, 0%
Sodium Chloride 2,5 %Sodium Chloride 2.5%
Water 74,5 %Water 74.5%
Preservative, Perfume q.s. Preservative, Perfume q.s.
Body Wash Body wash
TEGO® Betain AB 1214; 30% (Coco TEGO ® betaine AB 1214; 30% (Coco
30,0 % Betaine)  30.0% betaine)
Rhamnolipid; 76,9% 4,0 % rhamnolipid; 76.9% 4.0%
TEGO® Carbomer 841 SER 1 ,0 %TEGO Carbomer ® 841 SER 1, 0%
Water 65,0 %Water 65.0%
Preservative, Perfume q.s. Preservative, Perfume q.s.
Body Wash Body wash
TEGO® Betain AB 1214; 30% (Coco TEGO ® betaine AB 1214; 30% (Coco
20,0 % Betaine)  20.0% betaine)
Rhamnolipid; 76,9% 8,0 % rhamnolipid; 76.9% 8.0%
TEGO® Carbomer 841 SER 1 ,0 %TEGO Carbomer ® 841 SER 1, 0%
Water 71 ,0 %Water 71, 0%
Preservative, Perfume q.s. Preservative, Perfume q.s.
Body Wash Body wash
Lauryl Glucoside; 50% 12,0 % Lauryl glucoside; 50% 12.0%
Rhamnolipid; 76,9% 8,0 %rhamnolipid; 76.9% 8.0%
TEGO® Carbomer 841 SER 1 ,0 %TEGO Carbomer ® 841 SER 1, 0%
Water 79,0 %Water 79.0%
Preservative, Perfume q.s. Body Wash Preservative, perfume qs Body wash
REWOTERIC® AM C; 32% (Sodium REWOTERIC AM ® C; 32% (Sodium
9,5 % Cocoamphoacetate)  9.5% cocoamphoacetate)
Rhamnolipid; 76,9% 1 1 ,5 % rhamnolipid; 76.9% 1 1, 5%
TEGO® Carbomer 841 SER 1 ,0 %TEGO Carbomer ® 841 SER 1, 0%
Water 78,0 %Water 78.0%
Preservative, Perfume q.s. Preservative, Perfume q.s.

Claims

Ansprüche claims
1 . Kosmetische Formulierung enthaltend 1 . Contains cosmetic formulation
A) mindestens ein alkylmodifizierte Carboxylgruppen aufweisendes,  A) at least one alkyl-modified carboxyl group-containing,
wasserlösliches Copolymer, welches erhältlich ist durch Polymerisation von 100 Gewichtsteilen Acryl- oder Methacylsäure,  water-soluble copolymer obtainable by polymerization of 100 parts by weight of acrylic or methacrylic acid,
0,5 bis 10 Gewichtsteilen Alkyl-Acrylat oder Alkyl-Methacylat wobei die Alkylgruppe ausgewählt ist aus Alkylgruppen mit 12 bis 24  0.5 to 10 parts by weight of alkyl acrylate or alkyl methacylate wherein the alkyl group is selected from alkyl groups of 12 to 24
Kohlenstoffatomen und  Carbon atoms and
0 bis 0,1 Gewichtsteilen einer Substanz enthaltend zwei oder mehr  0 to 0.1 parts by weight of a substance containing two or more
ethylenisch ungesättigte Reste,  ethylenically unsaturated radicals,
wobei eine neutralisierte, 1 gew.-%ige Lösung des Polymers in Wasser eine Viskosität von 1000 mPa s oder niedriger und eine Transmission von 90 % oder höher aufweist und diese Lösung bei einer Zugabe von 0,25 bis 7 Gewichtsteilen NaCI auf 100 Gewichtsteile dieser Lösung eine höchste Viskosität von 10000 bis 40000 mPa s und eine Transmission von 90 % oder höher aufweist und  wherein a neutralized, 1 wt .-% solution of the polymer in water has a viscosity of 1000 mPa s or lower and a transmission of 90% or higher, and this solution with an addition of 0.25 to 7 parts by weight NaCl to 100 parts by weight of this Solution has a highest viscosity of 10,000 to 40,000 mPa s and a transmission of 90% or higher, and
B) mindestens ein Tensid ausgewählt aus der Gruppe bestehend aus  B) at least one surfactant selected from the group consisting of
Sulfosuccinate und Biotenside.  Sulfosuccinates and biosurfactants.
2. Kosmetische Formulierung gemäß Anspruch 1 , dadurch gekennzeichnet, dass A), mindestens ein alkylmodifizierte Carboxylgruppen aufweisendes, 2. Cosmetic formulation according to claim 1, characterized in that A), at least one alkyl-modified carboxyl groups having,
wasserlösliches Copolymer, welches erhältlich ist durch Polymerisation von 100 Gewichtsteilen Acryl- oder Methacylsäure,  water-soluble copolymer obtainable by polymerization of 100 parts by weight of acrylic or methacrylic acid,
0,5 bis 5 Gewichtsteilen Alkyl-Acrylat oder Alkyl-Methacylat wobei die  0.5 to 5 parts by weight of alkyl acrylate or alkyl methacylate wherein the
Alkylgruppe ausgewählt ist aus Alkylgruppen mit 18 bis 24  Alkyl group is selected from alkyl groups having 18 to 24
Kohlenstoffatomen und  Carbon atoms and
0 bis 0,1 Gewichtsteilen einer Substanz enthaltend zwei oder mehr  0 to 0.1 parts by weight of a substance containing two or more
ethylenisch ungesättigte Reste,  ethylenically unsaturated radicals,
wobei eine neutralisierte, 1 gew.-%ige Lösung des Polymers in Wasser eine Viskosität von 1500 mPa s oder niedriger und eine Transmission von 90 % oder höher aufweist und diese Lösung bei einer Zugabe von 0,25 bis 5 Gewichtsteilen NaCI auf 100 Gewichtsteile dieser Lösung eine höchste Viskosität von 15000 bis 40000 mPa s und eine Transmission von 90 % oder höher aufweist,  wherein a neutralized, 1 wt .-% solution of the polymer in water has a viscosity of 1500 mPa s or lower and a transmission of 90% or higher, and this solution with an addition of 0.25 to 5 parts by weight NaCl to 100 parts by weight of this Solution has a highest viscosity of 15,000 to 40,000 mPa s and a transmission of 90% or higher,
ist. Kosmetische Formulierung gemäß Anspruch 1 , dadurch gekennzeichnet, dass A) mindestens ein alkylmodifizierte Carboxylgruppen aufweisendes, is. Cosmetic formulation according to Claim 1, characterized in that A) has at least one alkyl-modified carboxyl group-containing,
wasserlösliches Copolymer, welches erhältlich ist durch Polymerisation von water-soluble copolymer obtainable by polymerization of
100 Gewichtsteilen Acryl- oder Methacylsäure, 100 parts by weight of acrylic or methacrylic acid,
5 bis 10 Gewichtsteilen Lauryl-Acrylat oder Lauryl-Methacylsäuret und 5 to 10 parts by weight of lauryl acrylate or lauryl methacylic acid and
0 bis 0,1 Gewichtsteilen einer Substanz enthaltend zwei oder mehr 0 to 0.1 parts by weight of a substance containing two or more
ethylenisch ungesättigte Reste,  ethylenically unsaturated radicals,
wobei eine neutralisierte, 1 gew.-%ige Lösung des Polymers in Wasser eine Viskosität von 1000 mPa s oder niedriger und eine Transmission von 95 % oder höher aufweist und diese Lösung bei einer Zugabe von 1 bis 7 Gewichtsteilen NaCI auf 100 Gewichtsteile dieser Lösung eine höchste Viskosität von 10000 bis 30000 mPa s und eine Transmission von 95 % oder höher aufweist, wherein a neutralized, 1 wt .-% solution of the polymer in water has a viscosity of 1000 mPa s or lower and a transmission of 95% or higher, and this solution with an addition of 1 to 7 parts by weight NaCl to 100 parts by weight of this solution highest viscosity of 10000 to 30,000 mPa s and a transmission of 95% or higher,
ist. is.
Kosmetische Formulierung gemäß mindestens einem der vorherigen Ansprüche, dadurch gekennzeichnet, dass die Substanz enthaltend zwei oder mehr ethylenisch ungesättigte Reste ausgewählt ist aus der Gruppe bestehend aus Pentaerythritol Allyl Ether, Diethylen Glycol Diallyl Ether, Polyethylen Glycol Diallyl Ether und Polyallyl Saccharose. Cosmetic formulation according to at least one of the preceding claims, characterized in that the substance containing two or more ethylenically unsaturated radicals is selected from the group consisting of pentaerythritol allyl ether, diethylene glycol diallyl ether, polyethylene glycol diallyl ether and polyallyl sucrose.
Kosmetische Formulierung gemäß mindestens einem der vorherigen Ansprüche, dadurch gekennzeichnet, dass der Anteil der Komponente A) an der Cosmetic formulation according to at least one of the preceding claims, characterized in that the proportion of component A) at the
erfindungsgemäßen Formulierung von 0,01 bis 10 Gew.-% beträgt. inventive formulation of 0.01 to 10 wt .-% is.
Kosmetische Formulierung gemäß mindestens einem der vorherigen Ansprüche, dadurch gekennzeichnet, dass der Anteil der Komponente B) an der Cosmetic formulation according to at least one of the preceding claims, characterized in that the proportion of component B) at the
erfindungsgemäßen Formulierung von 0,1 bis 30 Gew.-% beträgt. inventive formulation of 0.1 to 30 wt .-% is.
Kosmetische Formulierung gemäß mindestens einem der vorherigen Ansprüche, dadurch gekennzeichnet, dass das Biotensid ausgewählt ist aus der Gruppe bestehend aus Rhamnolipide, Sophorolipide, Glucoselipide, Celluloselipide und Trehaloselipide. Cosmetic formulation according to at least one of the preceding claims, characterized in that the biosurfactant is selected from the group consisting of rhamnolipids, sophorolipids, glucoselipids, celluloselipids and trehaloselipids.
8. Kosmetische Formulierung gemäß mindestens einem der vorherigen Ansprüche, dadurch gekennzeichnet, dass sie enthält mindestens einen ausgewählt aus der Gruppe: 8. Cosmetic formulation according to at least one of the preceding claims, characterized in that it contains at least one selected from the group:
C) ammonium-, phosphonium-, imidazolinium- oder imidazolium-Gruppen- haltigen Verbindungen, insbesondere ein Alkylquat, ein Dialkylquat und ein Esterquat, und kationischen Polymere.  C) ammonium, phosphonium, imidazolinium or imidazolium group-containing compounds, in particular an alkyl quat, a dialkyl quat and an esterquat, and cationic polymers.
9. Kosmetische Formulierung gemäß Anspruch 8, dadurch gekennzeichnet, dass C) ausgewählt ist aus der Gruppe bestehend aus: Hydroxypropyl guar 9. A cosmetic formulation according to claim 8, characterized in that C) is selected from the group consisting of: hydroxypropyl guar
hydroxypropyltrimonium Chloride, Polyquaternium 7, Polyquaternium 10 und Polyquaternium 1 1 , und Silicone Quaternium-22 (ABIL® T Quat 60 und ABIL ME 45). hydroxypropyltrimonium chloride, Polyquaternium 7, Polyquaternium 10 and Polyquaternium 1 1, and Silicone Quaternium-22 (ABIL Quat ® T 60 and ABIL ME 45).
10. Kosmetische Formulierung gemäß mindestens einem der vorherigen Ansprüche, dadurch gekennzeichnet, dass sie im Wesentlichen frei von alkoxylierten 10. Cosmetic formulation according to at least one of the preceding claims, characterized in that they are substantially free of alkoxylated
Verbindungen ist.  Connections is.
1 1. Kosmetische Formulierung gemäß mindestens einem der vorherigen Ansprüche, dadurch gekennzeichnet, dass sie im Wesentlichen frei Sulfaten ist. 1 1. A cosmetic formulation according to any one of the preceding claims, characterized in that it is substantially free sulfates.
12. Verwendung mindestens eines alkylmodifizierte Carboxylgruppen aufweisenden, wasserlöslichen Copolymers, 12. Use of at least one alkyl-modified carboxyl-containing, water-soluble copolymer,
welches erhältlich ist durch Polymerisation von  which is obtainable by polymerization of
100 Gewichtsteilen Acryl- oder Methacylsäure,  100 parts by weight of acrylic or methacrylic acid,
0,5 bis 10 Gewichtsteilen Alkyl-Acrylat oder Alkyl-Methacylat wobei die 0.5 to 10 parts by weight of alkyl acrylate or alkyl methacylate wherein the
Alkylgruppe ausgewählt ist aus Alkylgruppen mit 12 bis 24 Alkyl group is selected from alkyl groups having 12 to 24
Kohlenstoffatomen und  Carbon atoms and
0 bis 0,1 Gewichtsteilen einer Substanz enthaltend zwei oder mehr  0 to 0.1 parts by weight of a substance containing two or more
ethylenisch ungesättigte Reste,  ethylenically unsaturated radicals,
wobei eine neutralisierte, 1 gew.-%ige Lösung des Polymers in Wasser eine  wherein a neutralized, 1 wt .-% solution of the polymer in water a
Viskosität von 1000 mPa s oder niedriger und eine Transmission von 90 % oder höher aufweist und diese Lösung bei einer Zugabe von 0,25 bis 7 Gewichtsteilen NaCI auf 100 Gewichtsteile dieser Lösung eine höchste Viskosität von 10000 bis 40000 mPa s und eine Transmission von 90 % oder höher aufweist zur Verdickung einer kosmetischen Formulierung enthaltend mindestens ein Tensid ausgewählt aus der Gruppe bestehend aus Sulfosuccinate und Biotenside. Viscosity of 1000 mPa s or lower and a transmission of 90% or higher, and this solution with an addition of 0.25 to 7 parts by weight NaCl to 100 parts by weight of this solution has a highest viscosity of 10,000 to 40,000 mPa s and a transmission of 90% or higher for thickening a cosmetic formulation comprising at least one surfactant selected from the group consisting of sulfosuccinates and biosurfactants.
EP14715574.1A 2013-04-10 2014-04-03 Cosmetic formulation containing copolymer and sulfosuccinate and/or biosurfactant Ceased EP2983638A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102013206314.8A DE102013206314A1 (en) 2013-04-10 2013-04-10 Cosmetic formulation containing copolymer as well as sulfosuccinate and / or biosurfactant
PCT/EP2014/056637 WO2014166796A1 (en) 2013-04-10 2014-04-03 Cosmetic formulation containing copolymer and sulfosuccinate and/or biosurfactant

Publications (1)

Publication Number Publication Date
EP2983638A1 true EP2983638A1 (en) 2016-02-17

Family

ID=50440649

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14715574.1A Ceased EP2983638A1 (en) 2013-04-10 2014-04-03 Cosmetic formulation containing copolymer and sulfosuccinate and/or biosurfactant

Country Status (7)

Country Link
US (1) US20160045424A1 (en)
EP (1) EP2983638A1 (en)
JP (1) JP2016515637A (en)
CN (1) CN105142608A (en)
BR (1) BR112015025561A2 (en)
DE (1) DE102013206314A1 (en)
WO (1) WO2014166796A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2949214A1 (en) 2014-05-26 2015-12-02 Evonik Degussa GmbH Methods of producing rhamnolipids
EP3002328A1 (en) * 2014-09-30 2016-04-06 Evonik Degussa GmbH Formulation containing biotensides
BR112018015499B1 (en) * 2016-02-16 2022-03-22 Rhodia Operations Sulfate-free aqueous composition for personal care and use of such compositions
JP6935390B2 (en) * 2016-03-31 2021-09-15 住友精化株式会社 Gel composition, cosmetics, and method of manufacturing gel composition
CN108883052A (en) * 2016-03-31 2018-11-23 住友精化株式会社 The manufacturing method of gel combination, cosmetic preparation and gel combination
CH712860A2 (en) 2016-08-29 2018-03-15 Remo Richli Agents with alkoxylated fatty acid amides and glycolipid biosurfactants.
CH712859A2 (en) 2016-08-29 2018-03-15 Remo Richli Washing, care and cleaning preparations containing polyoxyalkylene carboxylate and glycolipid biosurfactant.
WO2019154970A1 (en) 2018-02-09 2019-08-15 Evonik Degussa Gmbh Mixture composition comprising glucolipids
WO2019219303A1 (en) * 2018-05-17 2019-11-21 Unilever Plc Cleaning composition
CN112119147B (en) * 2018-05-17 2023-09-29 联合利华知识产权控股有限公司 cleaning composition
DE102018210175A1 (en) * 2018-06-22 2019-12-24 Beiersdorf Ag Mild cosmetic cleaning preparation
CN112513236A (en) * 2018-07-17 2021-03-16 联合利华知识产权控股有限公司 Use of rhamnolipids in surfactant systems
JP7475821B2 (en) * 2019-06-25 2024-04-30 ロレアル Compositions Comprising Biosurfactants and Carboxybetaine Polymers - Patent application
US11918670B2 (en) 2020-03-11 2024-03-05 Evonik Operations Gmbh Mixture composition comprising glycolipids and triethyl citrate

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090227751A1 (en) * 2005-11-14 2009-09-10 Sumitomo Seika Chemicals Co., Ltd. Water-soluble copolymer having alkyl-modified carboxyl groups

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6037087B2 (en) 1978-09-28 1985-08-24 花王株式会社 cosmetics
JPS60183032A (en) 1984-03-02 1985-09-18 Shiseido Co Ltd Emulsified composition
JPH064665B2 (en) 1988-05-30 1994-01-19 工業技術院長 Metal soap
CA2060698C (en) 1991-02-12 1997-09-30 Peter J. Hall Detergent compositions
FR2740779B1 (en) 1995-11-08 1997-12-05 Rhone Poulenc Chimie COMPOSITION BASED ON ENZYME AND SOPHOROLIPIDE IN LACTONE FORM AND USE THEREOF IN DETERGENT FORMULATIONS FOR THE WASHING OF LAUNDRY
DE19600743A1 (en) 1996-01-11 1997-07-24 Henkel Kgaa Use of mixture of glyco-lipid and surfactant in hand dish-washing detergent
DE19648439A1 (en) 1996-11-22 1998-05-28 Henkel Kgaa Skin-friendly washing=up liquid with good cleaning performance
CN1141357C (en) 2000-08-09 2004-03-10 大庆油田有限责任公司勘探开发研究院 Oil-displacing agent and its application
JP2003013093A (en) 2001-06-27 2003-01-15 Saraya Kk Low foaming detergent composition
FR2827192B1 (en) 2001-07-13 2004-06-04 Cognis France Sa PREPARATIONS CONTAINING NON-IONIC SURFACTANTS AS EXTRACTING AGENTS
DE10216497A1 (en) * 2002-04-11 2003-10-30 Beiersdorf Ag shampoo
KR20040033376A (en) 2002-10-14 2004-04-28 주식회사 엘지생활건강 Cosmetics composition comprising sophorolipids
ATE328989T1 (en) 2003-01-28 2006-06-15 Ecover Belgium CLEANING AGENT COMPOSITIONS
FR2855752B1 (en) 2003-06-03 2005-08-26 Lvmh Rech COSMETIC USE OF SOPHOROLIPIDS AS REGULATORY AGENTS OF SUB-CUTANEOUS ADIPOSE MASS AND APPLICATION TO SLURRY
JP4548827B2 (en) 2004-09-06 2010-09-22 サラヤ株式会社 Biodegradable liquid detergent composition
JP2006083238A (en) 2004-09-14 2006-03-30 Saraya Kk Cleanser composition
US7556654B1 (en) 2004-10-15 2009-07-07 Naturell Methods for cleaning materials
JP2006274233A (en) 2005-03-29 2006-10-12 Saraya Kk Bleaching agent composition
EP1953176B1 (en) 2005-11-21 2011-07-06 Sumitomo Seika Chemicals Co., Ltd. Water-soluble copolymer having alkyl-modified carboxyl group
JP4858946B2 (en) 2006-01-10 2012-01-18 独立行政法人産業技術総合研究所 Emulsifier or solubilizer
EP2046930A4 (en) 2006-07-27 2012-06-27 Aurora Advance Beauty Labs Rhamnolipid-based formulations
JP5294226B2 (en) 2006-09-07 2013-09-18 独立行政法人産業技術総合研究所 W / O type microemulsion
JP2009084502A (en) * 2007-10-02 2009-04-23 Shiseido Co Ltd Detergent composition and its producing method
JP5305677B2 (en) * 2008-02-05 2013-10-02 株式会社 資生堂 Cleaning fee
DE102008038137A1 (en) * 2008-08-18 2010-02-25 Henkel Ag & Co. Kgaa Sulfate-free mild surfactant system for skin and hair cleansing
JP5470857B2 (en) * 2009-01-07 2014-04-16 独立行政法人産業技術総合研究所 Microorganism having ability to produce sugar-type biosurfactant and method for producing sugar-type biosurfactant using the same
JP5447967B2 (en) * 2009-09-04 2014-03-19 独立行政法人産業技術総合研究所 Reverse vesicle composed of biosurfactant
EP2504386B1 (en) * 2009-11-23 2017-03-22 Lubrizol Advanced Materials, Inc. Surfactant-polymer blends
JP2011178766A (en) * 2010-03-04 2011-09-15 Toyobo Co Ltd Oil-in-water type emulsified composition
EP2552389B1 (en) * 2010-03-31 2017-05-03 Unilever PLC Mild to the skin, foaming detergent composition
CN102933190A (en) * 2010-06-11 2013-02-13 宝洁公司 Compositions for treating skin
DE102011090030A1 (en) * 2011-12-28 2013-07-04 Evonik Industries Ag Aqueous hair and skin cleansing compositions containing biosurfactants
DE102012201598A1 (en) 2012-02-03 2013-08-08 Evonik Industries Ag Polyglycol ether-free sulfosuccinates based on polyglycerol partial esters and their use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090227751A1 (en) * 2005-11-14 2009-09-10 Sumitomo Seika Chemicals Co., Ltd. Water-soluble copolymer having alkyl-modified carboxyl groups

Also Published As

Publication number Publication date
CN105142608A (en) 2015-12-09
DE102013206314A1 (en) 2014-10-16
BR112015025561A2 (en) 2017-07-18
WO2014166796A1 (en) 2014-10-16
JP2016515637A (en) 2016-05-30
US20160045424A1 (en) 2016-02-18

Similar Documents

Publication Publication Date Title
EP2983638A1 (en) Cosmetic formulation containing copolymer and sulfosuccinate and/or biosurfactant
EP2881381B1 (en) Polyglycerine partial esters, their preparation and use
WO2014170025A1 (en) Composition containing oil bodies, fatty acids, amino acid surfactants, and n-methyl-n-acylglucamines
EP2931378B1 (en) Cosmetic preparations with a flow point
EP3013427A2 (en) Use of special n-alkyl-n-acylglucamines for conditioning hair in hair washing agents
EP2637637B1 (en) Composition comprising mixtures of isostearamide, glycerol ester and water
DE19641274C1 (en) Oil in water microemulsion sun protection cosmetic products
WO1999006514A1 (en) Aqueous pearlescent concentrates
DE10234257A1 (en) Self-warming cosmetic cleansing cloth is impregnated with a polyalcohol (e.g. polyethyleneglycol) which generates heat on contact with water
DE19621681A1 (en) Aqueous pearlescent concentrates
DE19624455C2 (en) Sunscreen in the form of O / W microemulsions
EP3744310B1 (en) Compositions containing sorbitan carboxylic acid esters and glycerin carboxylic acid esters
DE102021121539A1 (en) A hair treatment composition comprising trimethylglycine based hair conditioning agent and a natural thickener
CH697291B1 (en) Kiare and aqueous cosmetic and dermatological light protection formulations containing water- and oil-soluble UV filter substances.
EP4041412A1 (en) Cleansing preparation containing caesalpinia spinosa gum
EP3215111A1 (en) Shower lotions i
EP0836471A1 (en) Skin-care agents containing nonionic surfactants and cationic biopolymers
DE102013225846A1 (en) Cosmetic composition containing a combination of proteolipids and ceramides
EP0999822A1 (en) Aqueous pearly lustre concentrates
EP3930675B1 (en) Glycolipid containing cleansing composition comprising micelles
EP3215113A1 (en) Shower lotions ii
WO2022233478A1 (en) Protection of hair against environmental influence with a phenol and multivalent cations
DE102020204994A1 (en) HAIR COMPOSITIONS MADE FROM A MODIFIED POLYSACCHARIDE AND HIGH VALUE IONS
DE102021121541A1 (en) A hair treatment composition comprising a trimethylglycine based hair conditioning agent and an active
WO2022233515A1 (en) Multipotent hair washing composition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150904

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20170316

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: EVONIK DEGUSSA GMBH

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: EVONIK OPERATIONS GMBH

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20200522